Patents Examined by Jennifer A Berrios
  • Patent number: 11318072
    Abstract: The present invention relates to a cosmetic and/or dermatological composition comprising, in a physiologically acceptable medium: a) at least some hydrophobic aerogel particles, b) at least some silicone elastomer particles, c) at least one particle that absorbs sebum. The invention also relates to a process for making the skin matt and/or for reducing its shine.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: May 3, 2022
    Assignee: L'OREAL
    Inventors: Patricia Pierre, Eric Lheureux
  • Patent number: 11306051
    Abstract: The present invention relates to the use, in a cosmetic, dermatological or pharmaceutical composition, of at least one compound of formula (I): in which: R2 represents a hydrogen atom or a methyl or ethyl radical; R3 represents a linear C1-C12 alkyl radical, optionally substituted with a hydroxyl group; or a linear C2-C12 alkenyl radical, optionally substituted with a hydroxyl group; as a preserving agent. The invention also relates to certain novel compounds and to the cosmetic, dermatological or pharmaceutical compositions comprising them.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: April 19, 2022
    Assignee: L'OREAL
    Inventor: Maria Dalko
  • Patent number: 11291730
    Abstract: A composition for treating a wound includes graphene oxide (GO) and hyaluronic acid (HA) that are covalently linked, XAV939, and water. The composition can also include a surfactant, such as PEG. The composition can be topically administered to a subject to treat a wound of the subject. Methods of treating a wound using the composition are also provided.
    Type: Grant
    Filed: October 6, 2018
    Date of Patent: April 5, 2022
    Assignee: ELUCIDERM INC.
    Inventor: Daniel D Holsworth
  • Patent number: 11266584
    Abstract: The present invention relates to a cosmetic composition comprising, at least: (i) at least one composite pigment comprising at least one small particle with a mean particle size of more than 100 nm and less than 1 ?m, preferably less than 600 nm, and more preferably less than 400 nm, wherein the surface of the small particle is at least in part covered with at least one coating layer comprising at least one inorganic or organic particulate solid UV filter; (ii) at least one organopolysiloxane elastomer; and (iii) at least one oil absorbing agent with oil absorption capability of 1 ml/1 g or more in an amount of more than 1% by weight relative to the total weight of composition.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: March 8, 2022
    Assignee: L'OREAL
    Inventors: Romain Tachon, Momoko Shimizu, Shinichi Matsufuji
  • Patent number: 11248093
    Abstract: An inverse emulsion copolymer composition comprises (A) an aqueous phase comprising a cross-linked hydrophilic polyelectrolyte copolymer (A?) obtained by the free radical copolymerisation of: (i) at least one anionic ethylenically unsaturated monomer bearing a negatively charged group and one polymerisable C?C double bond, or at least one cationic ethylenically unsaturated monomer bearing a positively charged group and one polymerisable C?C double bond, and (ii) at least one non-ionic ethylenically unsaturated cross-linking monomer bearing at least two polymerisable C?C double bonds, and (iii) optionally, one or more hydrophilic non-ionic ethylenically unsaturated monomers bearing one polymerisable C?C double bond, (B) an oil phase comprising a carrier oil (C), (D) (i) at least one water-in-oil emulsifying surfactant, and (D) (ii) at least one oil-in-water emulsifying surfactant; characterised in that the carrier oil component (C) of the oil phase comprises from 75% to 100%, by weight of the said carrier oil
    Type: Grant
    Filed: October 4, 2018
    Date of Patent: February 15, 2022
    Assignee: Scott Bader Company LTD.
    Inventors: Lee Camilleri, Clive Noel Williams, Paul Edward Hunt
  • Patent number: 11241453
    Abstract: The present invention is predicated on the realisation that problems with the poor water solubility of arsenic trioxide and the extreme difficulty in dissolving arsenic trioxide in anything other than a very basic solution, could be overcome by forming a much more soluble diarsenic tetraoxide, including the compound NaHAs2O4, prior to its delivery to a patient. Pharmaceutical compositions with such compounds and their use in the treatment of cancers is disclosed.
    Type: Grant
    Filed: August 2, 2017
    Date of Patent: February 8, 2022
    Assignee: Eupharma Pty Ltd
    Inventor: Malvin Eutick
  • Patent number: 11241379
    Abstract: The present invention relates to a parenteral dosage form comprising a) a ready-to-infuse, stable aqueous solution comprising diltiazem or its pharmaceutically acceptable salt, pH adjusting agent to provide a pH in the range of 3 to 5 and ethanol, and b) an infusion container filled with said aqueous solution.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: February 8, 2022
    Assignee: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Samarth Kumar, Milan Natvarbhai Thakkar, Kandarp Maheshkumar Dave
  • Patent number: 11224564
    Abstract: Disclosed are a pharmaceutical composition and a beauty-purposed pharmaceutical composition for prevention or treatment of neuromuscular disease, the composition including a combination of Erigeron annuus flower-based essential oil and Botox. Erigeron annuus flower-based essential oil inhibits t-SNARE protein and v-SNARE protein expression in neurons to inhibit the formation of SNARE protein complexes. Erigeron annuus flower-based essential oil inhibits the regeneration of t-SNARE protein and v-SNARE protein degraded by Botox to inhibit neurotransmitter release. Accordingly, an efficacy duration of Botox may be extended. Thus, Erigeron annuus flower-based essential oil may be usefully used in combination with Botox as Botox adjuvant for the prevention and treatment of neuromuscular disease or for beauty.
    Type: Grant
    Filed: September 11, 2018
    Date of Patent: January 18, 2022
    Assignee: HOSEO UNIVERSITY ACADEMIC COOPERATION FOUNDATION
    Inventors: Hwan-Myung Lee, Dae-Il Hwang, Do-Yoon Kim, Soo-Min Park, Ha-Bin Kim
  • Patent number: 11213493
    Abstract: A topical preparation containing vitamin K1 and a preparation method thereof are provided. The topical preparation includes the following components in weight percentage: 0.01-5% of vitamin K1, 0.1-25% of a transdermal enhancer and 70-99% of a matrix for the topical preparation. The transdermal enhancer is composed of urea, menthol and Eucalyptus oil in a mass ratio of (5-6):(2-3):(1-3). The topical preparation containing vitamin K1 can be used to treat moderate and severe skin toxicity caused by anti-tumor drugs related to epidermal growth factor receptor (EGFR), can effectively treat diseases such as acne-like rash, pruritus, red swelling, dry skin and mucositis caused by EGFR-related anti-tumor drugs, and can ensure the continued treatment with anti-EGFR targeting drugs. It can increase the possibility of vitamin K1 reaching focus sites in the dermal layer through the stratum corneum, and can rapidly alleviate moderate and severe skin diseases caused by EGFR-related anti-tumor drugs.
    Type: Grant
    Filed: November 4, 2019
    Date of Patent: January 4, 2022
    Assignee: YANGZIJIANG PHARMACEUTICAL GROUP SHANGHAI HAINI PHARMACEUTICAL CO., LTD.
    Inventors: Haihua Ni, Xinguo Jiang, Feng Jiang, Yun Xu, Xin Pan, Weihong Zhuang
  • Patent number: 11197476
    Abstract: The compositions of the present invention comprise at least one medium polarity oil and at least one antibacterial agent, the combination of which produces a synergistic antibacterial effect against bacterial biofilms. Methods are disclosed for the reduction of bacteria in and/or elimination of bacterial biofilms on biological and non-biological surfaces, as well as methods for the treatment of wounds, skin lesions, mucous membrane lesions, and other biological surfaces infected or contaminated with bacterial biofilms.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: December 14, 2021
    Assignee: SMITH & NEPHEW, INC.
    Inventors: Aleksa Jovanovic, Lei Shi, Eric Roche, Paul Renick
  • Patent number: 11197816
    Abstract: To provide an acrylic silicone graft copolymer capable of effectively exerting a function in a composition for external application containing various oily components such as a natural oil, a hydrocarbon oil, ester oil and a silicone oil, and a composition for external application containing the acrylic silicone graft copolymer. A composition for external application including an acrylic silicone graft copolymer, which contains 2 to 25 mass % of a constitutional unit represented by formula (I), 55 to 85 mass % of a constitutional unit represented by formula (II) and 2 to 20 mass % of a constitutional unit represented by formula (III). wherein R1 is an alkyl group having 1 to 4 carbon atoms; R2 is an alkylene group having 2 to 10 carbon atoms; and n is an integer of 1 to 100.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: December 14, 2021
    Assignee: NOF CORPORATION
    Inventors: Hideyuki Yamaki, Tomomi Kuromiya, Chikako Ichikawa, Hisao Ito, Mitsuhiro Fukushima, Yuki Munekata
  • Patent number: 11197836
    Abstract: Vasoconstrictors are administered topically to provide protection against the adverse effects, e.g., alopecia, mucositis or dermatitis, induced by chemotherapy or radiotherapy. Appropriate dosages and formulations of topical vasoconstrictors are provided. Methods for the use of such compositions are also provided.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: December 14, 2021
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: William E. Fahl, Arnold E. Ruoho, Minesh Mehta
  • Patent number: 11179307
    Abstract: One embodiment of the present invention relates to a composition comprising: (a) at least one first anionic surfactant selected from glutamic acid compounds and salts thereof; (b) at least one second anionic surfactant selected from alanine compounds and salts thereof, glycine compounds and salts thereof, and mixtures thereof; (c) at least one nonionic surfactant; and (d) at least one thickener. One embodiment according to the present invention is stable and can form foam with good quality.
    Type: Grant
    Filed: November 24, 2017
    Date of Patent: November 23, 2021
    Assignee: L'OREAL
    Inventors: Shinobu Mitsuda, Kazuhiko Maruyama
  • Patent number: 11173130
    Abstract: A drug delivery system (DDS) including a hydrophobic porous scaffold and a hydrogel having a hydrophilic polymer and one or more biologic drugs provides sustained zero-order release of the one or more biologic drugs. Also provided herein are methods of making and using a DDS including a hydrophobic porous scaffold and a hydrogel having a hydrophilic polymer and one or more biologic drugs.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: November 16, 2021
    Assignee: Massachusetts Eye and Ear Infirmary
    Inventor: Eleftherios Paschalis Ilios
  • Patent number: 11173465
    Abstract: The present invention relates to a process for producing perfume- or flavor-containing polyurea microcapsules with improved deposition of encapsulated actives on targeted surfaces such as fiber, hair and skin, which can be used in home or personal care products, as well as to microcapsules obtainable by such a process and consumer products comprising these microcapsules.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: November 16, 2021
    Assignee: FIRMENICH SA
    Inventors: Lei Shi, Lahoussine Ouali, Lei Han
  • Patent number: 11160749
    Abstract: A cosmetic including an acryl silicone copolymer having a (meth)acrylic chain in the main chain and a structure containing at least a silicone macromonomer shown by the following general formula (1) as the monomer unit (the acryl silicone copolymer has a refractive index of 1.47 or more). A novel glossy cosmetic that is free from tautness or stiffness unlike previous silicone resin coatings, excellent in feeling of use, adherence, and flexibility, as well as good in effect for preventing color transfer.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: November 2, 2021
    Assignee: SHIN-ETSU CHEMICAL CO., LTD.
    Inventor: Hiroyuki Moriya
  • Patent number: 11154476
    Abstract: The disclosure provides personal care compositions that comprise a moisturizing agent of formula (I) wherein n is an integer from 2 to 5, R1 is independently H or C1-C3 alkyl and R2 is an unsubstituted linear or branched C1-C6 alkyl, at least one additional moisturizing agent and a cosmetically acceptable vehicle. In particular, the compound of formula (I) is diglycolamine acetamide. The compositions generally improve moisturization of skin and hair.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: October 26, 2021
    Assignee: NOURYON CHEMICALS INTERNATIONAL B.V.
    Inventors: Qiwei He, Hanamanthsa Bevinakatti
  • Patent number: 11154477
    Abstract: The disclosure provides personal care compositions that comprise a compound of formula (I) wherein n is an integer from 2 to 5, R1 is independently H or C1-C3 alkyl and R2 is an unsubstituted linear or branched C1-C6 alkyl and a cosmetically acceptable vehicle. In particular, the compound of formula (I) is diglycolamine acetamide The composition may be used to moisturise skin or hair.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: October 26, 2021
    Assignee: NOURYON CHEMICALS INTERNATIONAL B.V.
    Inventors: Qiwei He, Hanamanthsa Bevinakatti
  • Patent number: 11147302
    Abstract: The invention relates to the oral cosmetic use of a combination of active agents comprising at least taurine, a derivative thereof and/or an acceptable salt thereof and at least one grape extract, as cosmetic active agents for improving the quality of the nails. More particularly, the present invention relates to the oral cosmetic use of such a combination for improving the solidity of the nails and for reducing and/or preventing their splitting.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: October 19, 2021
    Assignee: NUTRICOS TECHNOLOGIES
    Inventors: Nathalie Piccardi, Yann Mahe, Carole Bru
  • Patent number: 11141381
    Abstract: A composition for an enteric hard capsule by taking advantage of conventionally unknown thermal gelation characteristics of a neutralized aqueous solution of an enteric polymer, so as to obtain an enteric capsule having sufficient water and acid resistances. More specifically, the composition has hypromellose acetate succinate having a molar substitution with an acetyl group per anhydroglucose unit of 0.6 to 0.8 and a ratio of the molar substitution with an acetyl group to a molar substitution with a succinyl group per anhydroglucose unit of 2.0 to 4.0, a neutralizer, and water method produces an enteric hard capsule having the steps of: immersing a core pin heated at 50 to 80° C. in the composition, taking the immersed core pin out of the composition, and drying a gel layer of the hypromellose acetate succinate formed on the taken-out core pin.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: October 12, 2021
    Assignee: SHIN-ETSU CHEMICAL CO., LTD.
    Inventor: Naosuke Maruyama